STERIS (NYSE:STE) Releases FY25 Earnings Guidance

STERIS (NYSE:STE) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $9.05-$9.25 for the period, compared to the consensus estimate of $9.16. STERIS also updated its FY 2025 guidance to 9.050-9.250 EPS.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday. KeyCorp increased their price objective on shares of STERIS from $255.00 to $265.00 and gave the company an “overweight” rating in a research note on Tuesday, September 3rd. Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. StockNews.com downgraded STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Finally, Stephens reissued an “overweight” rating and issued a $260.00 price objective on shares of STERIS in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $253.00.

STERIS Stock Performance

NYSE STE traded up $3.69 on Friday, hitting $219.19. 1,071,783 shares of the stock traded hands, compared to its average volume of 490,598. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.49 and a current ratio of 2.33. The business’s fifty day moving average is $232.29 and its two-hundred day moving average is $227.64. STERIS has a 12 month low of $195.47 and a 12 month high of $248.24. The firm has a market capitalization of $21.62 billion, a price-to-earnings ratio of 50.03 and a beta of 0.85.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, topping the consensus estimate of $2.11 by $0.03. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. STERIS had a return on equity of 13.91% and a net margin of 8.02%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.03 EPS. As a group, equities analysts anticipate that STERIS will post 9.02 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be issued a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.04%. STERIS’s dividend payout ratio (DPR) is 52.05%.

Insider Activity

In other news, CFO Michael J. Tokich sold 23,332 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the completion of the transaction, the chief financial officer now directly owns 42,930 shares in the company, valued at $10,603,710. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.14% of the company’s stock.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.